Log In
Print
BCIQ
Print
Print this Print this
 

Erbitux, cetuximab

Also known as: IMC-C225

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionChimeric IgG1 mAb targeting EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionBinds epidermal growth factor (EGF) receptor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today